Focus brief
$299one-time
One drug, treatment or acquisition target in one market.
Sourced activity summary, provider landscape and evidence gaps.
A sourced healthcare brief for your next drug, treatment or acquisition decision.
$299one-time
One drug, treatment or acquisition target in one market.
Sourced activity summary, provider landscape and evidence gaps.
$599one-time
One drug, treatment or acquisition target across up to three markets.
Comparative activity, provider landscape and market priorities with sources.
$999one-time
Up to three acquisition targets in one market.
Public-data target profiles, disclosed relationships and diligence questions. Not a valuation or financial audit.